JIZ ALPHONS JORDAN: Open Payments
NPI 1487103396 · SUGAR LAND, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$467 in 24 payments from 17 companies in 2025. Trend: 2023 $182 · 2024 $248 · 2025 $467
Food & beverage: $467
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 3 | $60 |
| Exact Sciences Corporation | 2 | $41 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $39 |
| Sumitomo Pharma America, Inc. | 2 | $37 |
| GlaxoSmithKline, LLC. | 2 | $36 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $34 |
| Alvogen Inc | 1 | $29 |
| AstraZeneca Pharmaceuticals LP | 1 | $28 |
| Lilly USA, LLC | 1 | $24 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $20 |
Products named: Cologuard Collection Kit, Wegovy, XIFAXAN, GEMTESA, TRELEGY ELLIPTA, CAPLYTA, TERIPARATIDE, AIRSUPRA.
Industry payments across TX — which companies pay providers there.
